Manchester Capital Management LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 143 filers reported holding IMMUNITYBIO INC in Q4 2021. The put-call ratio across all filers is 4.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Manchester Capital Management LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2022$1,000
-50.0%
2640.0%0.00%
Q4 2021$2,000
-33.3%
264
-14.3%
0.00%
Q3 2021$3,000
-25.0%
3080.0%0.00%
-100.0%
Q2 2021$4,000
-42.9%
3080.0%0.00%0.0%
Q1 2021$7,0003080.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders